TYRA
NASD Tyra Bioscience, Inc$20.60 ↑ +0.00 (+0.00%) Trading Up from the previous close of $20.60, $0.39 below the day’s high of $20.99
- YTD change
- -21.64%
- vs 20-day SMA
- +0.53%
- vs 200-day SMA
- -31.74%
Price ranges
Price & Performance
-16.22 (-44.21%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 49.3% away from all-time highs of $40.65
- TYRA is down 22% since the beginning of the year
- TYRA is up 40% over the past 12 months
- TYRA is down 19% over the past 1 month
- 13% of all TYRA investors are betting against TYRA
TYRA reads neutral: price sits above one of the two key moving averages, the 12-month move is +39.2%.
- Previous minute
- +$0.00
- Last hour
- +$0.40
- Last 5 days
- +10.99%
- vs 8-day SMA
- +6.90%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SNÃ…P, enables the rapid and precise refinement of structural design through iterative molecular SNÃ…Pshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA is developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family members, which are altered in approximately 7% of all cancers. The company was founded by Daniel Bensen and Todd Harris on August 2, 2018 and is headquartered in Carlsbad, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
